Published in Women's Health Weekly, July 14th, 2005
These effects were independent of blood glucose control, which remained stable after the therapies were changed. The study, named COMPLEMENT, was presented at the American Diabetes Association (ADA) 65th annual scientific sessions.
"These data suggest that people with type 2 diabetes on a statin who switch from Avandia to ACTOS may realize incremental...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.